Marissa Brittenham net worth and biography

Marissa Brittenham Biography and Net Worth

Chief Strategy Officer of Surgery Partners

Marissa Brittenham was appointed Chief Strategy Officer of Surgery Partners, Inc. in January 2022. Previously, Ms. Brittenham led Growth at Cityblock Health and Medicaid Partnerships at Evolent Health and was an Associate Partner at McKinsey & Company. She received a bachelor’s degree in Ethics, Politics and Economics from Yale University and earned her JD/ MBA from University of Pennsylvania Carey Law School and the Wharton School.

What is Marissa Brittenham's net worth?: The estimated net worth of Marissa Brittenham is at least $748,013.95 as of February 2nd, 2024. Ms. Brittenham owns 30,469 shares of Surgery Partners stock worth more than $748,014 as of April 27th. This net worth estimate does not reflect any other investments that Ms. Brittenham may own. Learn More about Marissa Brittenham's net worth.
How do I contact Marissa Brittenham?: The corporate mailing address for Ms. Brittenham and other Surgery Partners executives is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. Surgery Partners can also be reached via phone at (615) 234-5900 and via email at [email protected]. Learn More on Marissa Brittenham's contact information.
Has Marissa Brittenham been buying or selling shares of Surgery Partners?: Marissa Brittenham has not been actively trading shares of Surgery Partners during the last quarter. Most recently, Marissa Brittenham sold 1,637 shares of the business's stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $31.89, for a transaction totalling $52,203.93. Following the completion of the sale, the insider now directly owns 30,469 shares of the company's stock, valued at $971,656.41. Learn More on Marissa Brittenham's trading history.
Who are Surgery Partners' active insiders?: Surgery Partners' insider roster includes Jennifer Baldock (Insider), Harrison Bane (President of the American Group), Marissa Brittenham (Chief Strategy Officer), Laura Brocklehurst (Insider), Danielle Burkhalter (Chief Human Resources Officer), Thomas Cowhey (CFO), Teresa DeLuca (Director), Wayne DeVeydt (Chairman), David Doherty (CFO), Jason Evans (CEO), George Goodwin (Insider), Andrew Kaplan (Director), Bradley Owens (National Group President), Anthony Taparo (Insider), and Brent Turner (Director). Learn More on Surgery Partners' active insiders.
Are insiders buying or selling shares of Surgery Partners?: During the last twelve months, insiders at the sold shares 15 times. They sold a total of 8,031,894 shares worth more than $268,619,881.64. The most recent insider tranaction occured on March, 13th when CEO Jason Eric Evans sold 4,840 shares worth more than $143,796.40. Insiders at Surgery Partners own 2.6% of the company. Learn More about insider trades at Surgery Partners.
Information on this page was last updated on 3/13/2024.

Marissa Brittenham Insider Trading History at Surgery Partners

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/2/2024	Sell	1,637	$31.89	$52,203.93	30,469
2/2/2023	Sell	1,320	$35.90	$47,388.00	9,282

Marissa Brittenham Buying and Selling Activity at Surgery Partners

Surgery Partners Company Overview

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Today's Range

Now: $24.55

$23.86

$24.78

50 Day Range

MA: $28.49

$23.42

$34.23

2 Week Range

Now: $24.55

$22.05

$45.79

Volume

605,061 shs

Average Volume

897,786 shs

Market Capitalization

$3.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.71

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

From Banyan Hill Publishing | Ad

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details